SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CAMP

Camp4 Therapeutics Corp (NASDAQ:CAMP)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$3.79-$0.21 (-5.25%)
 
Market cap
$238M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 11, 2024
Market Cap$237.84M+13.8%
Revenue (ttm)$5.32M+39.9%
Net Income-$121.10M-126.8%
EPS-$2.05+17.7%
Shares Out62.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume89,478
Open$4.00
Previous Close$4.00
Day's Range$3.78 - $4.01
52-Week Range$2.90 - $7.75
Beta0.21
AnalystsBuy
Price Target$9.75(+157.26%)
Earnings DateMar 4, 2027

About CAMP

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Address
100 Talcott Avenue, Watertown, MA, 02472, US
Market Cap
238 million
Employees
48
Industrial Classification
Biotechnology

Camp4 Therapeutics Corp Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
1st Percentile Overall Score
CAMP InsiderScore:29 / 99

Camp4 Therapeutics Corp scored higher than 1% of companies evaluated by InsiderBuying, and ranked 95th out of 101 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Camp4 Therapeutics Corp bought $39.6K of stock across 1 purchase in the last 90 days, the largest of them $39.6K.

Stake Increase

None of these purchases could be measured against an existing holding, so this part of the factor scores on dollars alone.

New Positions

1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.50M
Bought
$99.05K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $8.00 (+108.6%)

1 firm rating CAMP in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Weak
From CAMP’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-5.25%
5 Days
-1.04%
1 Month
+11.80%
6 Months
-15.96%
1 Year
+13.81%

$CAMP stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CAMP holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CAMP's directors and management

Net Shares Purchased by Insiders−600k−300k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CAMP Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CAMP Revenue by Segment or Geography

$5.33MTotal
R&D$1.90M35.66%
Facilities-related and overhead$1.82M34.17%
Professional and consulting fees$1.36M25.63%
Travel and entertainment$242.00K4.54%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CAMP patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CAMP from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CAMP

VTIVanguard Morningstar Total Stock Market ETF$4.98M
IWMiShares Russell 2000 ETF$2.79M
VXFVanguard Extended Market ETF$2.04M
IWOiShares Russell 2000 Growth ETF$1.21M
VTWOVanguard Russell 2000 ETF$740.86K
IWCiShares Micro-Cap ETF$357.16K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CAMP’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
46.65
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
55

News check: Modest progress on SYNGAP1 trial with 2028 data timeline; routine corporate actions support neutral-to-slightly-positive outlook.

Recent Insider Activity

Buys
5
Sells
6
Buy Value
$99.05K
Distinct Buyers
4

Insider Score Trend Over Time

-28.2 since Sep 24
0255075100Sep 24 — Insider Score 53.1Sep 25 — Insider Score 60.0Sep 26 — Insider Score 59.9Sep 27 — Insider Score 59.9Sep 28 — Insider Score 60.0Sep 29 — Insider Score 59.6Sep 30 — Insider Score 59.3Oct 1 — Insider Score 58.9Oct 2 — Insider Score 47.0Oct 3 — Insider Score 58.5Oct 4 — Insider Score 58.5Oct 5 — Insider Score 58.5Oct 6 — Insider Score 58.5Oct 7 — Insider Score 58.1Oct 8 — Insider Score 58.0Oct 9 — Insider Score 57.8Oct 10 — Insider Score 57.5Oct 11 — Insider Score 58.0Oct 12 — Insider Score 58.0Oct 13 — Insider Score 57.9Oct 14 — Insider Score 57.6Oct 15 — Insider Score 57.6Oct 16 — Insider Score 57.4Oct 17 — Insider Score 57.4Oct 18 — Insider Score 57.5Oct 19 — Insider Score 57.3Oct 20 — Insider Score 57.3Oct 21 — Insider Score 57.1Oct 22 — Insider Score 57.1Oct 23 — Insider Score 57.1Oct 24 — Insider Score 57.0Oct 25 — Insider Score 56.8Oct 26 — Insider Score 56.8Oct 27 — Insider Score 56.8Oct 28 — Insider Score 56.6Oct 29 — Insider Score 56.4Oct 30 — Insider Score 55.8Oct 31 — Insider Score 55.6Nov 1 — Insider Score 35.3Nov 2 — Insider Score 35.2Nov 3 — Insider Score 34.6Nov 4 — Insider Score 34.1Nov 5 — Insider Score 33.5Nov 6 — Insider Score 32.7Nov 7 — Insider Score 32.1Nov 8 — Insider Score 33.0Nov 9 — Insider Score 33.5Nov 10 — Insider Score 32.3Nov 11 — Insider Score 31.5Nov 12 — Insider Score 31.5Nov 13 — Insider Score 30.3Nov 14 — Insider Score 29.4Nov 15 — Insider Score 30.0Nov 16 — Insider Score 29.9Nov 17 — Insider Score 28.5Nov 18 — Insider Score 27.7Nov 19 — Insider Score 26.6Nov 20 — Insider Score 25.0Nov 21 — Insider Score 24.4Nov 22 — Insider Score 25.0Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

IBRNiShares Neuroscience and Healthcare ETF0.23%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.22%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.18%
PQSVPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF0.15%
DMRSDeltaShares S&P 600 Managed Risk ETF0.06%
FSEGFidelity Enhanced Small Cap Growth ETF0.02%

Weight is the stock’s share of each fund’s holdings.